Stock Events

Stock Events

Global Cord Blood 

$0.9510
2
-$0.00-0.26% Friday 15:03

Statistics

Day High
0.75
Day Low
0.75
52W High
1.45
52W Low
0.2
Volume
600
Avg. Volume
5,790
Mkt Cap
115.6M
P/E Ratio
3.39
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Aug 18
$0.08
Jul 18
$0.08
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29NovExpected
Q3 2019
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
0.14
0.47
0.81
1.14
Expected EPS
N/A
Actual EPS
N/A

Financials

40.29%Profit Margin
Profitable
2016
2017
2018
2019
2020
2021
194.28MRevenue
78.27MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Computer Modelling Group
CMDXF
Mkt Cap218.23M
Cordlife Group Limited, based in Singapore, provides cord blood and cord lining banking services, competing in the Asian market.
Stem
STEM
Mkt Cap52.37M
StemCells, Inc. is involved in the development of stem cell therapies, which can use cord blood-derived stem cells, thus competing for similar resources.
Mesoblast
MESO
Mkt Cap2.26B
Mesoblast Limited develops therapies using mesenchymal lineage adult stem cells, competing in the broader stem cell therapy market.

About

Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes. As of March 31, 2022, the corporation oversaw the management of three distinct cord blood banks, located in Beijing municipality, Guangdong province, and Zhejiang province. The entity previously operated as China Cord Blood Corporation, adopting its current name in March 2018, and functions as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Show more...
CEO
Ting Zheng
Employees
1202
Country
Cayman Islands
ISIN
KYG393421030

Listings

OTC Link
US
CORBF

0 Comments

Share your thoughts

FAQ

What is Global Cord Blood stock price today?▼
The current price of CORBF is $0.95 USD — it has decreased by -0.26% in the past 24 hours. Watch Global Cord Blood stock price performance more closely on the chart.
What is Global Cord Blood stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Global Cord Blood stocks are traded under the ticker CORBF.
Is Global Cord Blood stock price growing?▼
CORBF stock has risen by +0.11% compared to the previous week, the month change is a +0.11% rise, over the last year Global Cord Blood has showed a -9.43% decrease.
What is Global Cord Blood market cap?▼
Today Global Cord Blood has the market capitalization of 115.6M
What is Global Cord Blood revenue for the last year?▼
Global Cord Blood revenue for the last year amounts to 194.28M USD.
What is Global Cord Blood net income for the last year?▼
CORBF net income for the last year is 78.27M USD.
Does Global Cord Blood pay dividends?▼
Yes, CORBF dividends are paid en. The last dividend per share was 0.08 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Global Cord Blood have?▼
As of September 05, 2026, the company has 1,202 employees.
In which sector is Global Cord Blood located?▼
Global Cord Blood operates in the Health & Wellness sector.
When did Global Cord Blood complete a stock split?▼
Global Cord Blood has not had any recent stock splits.
Where is Global Cord Blood headquartered?▼
Global Cord Blood is headquartered in Hong Kong, Cayman Islands.